Skip to main content
SpringerLink
Log in

Role of Cerebral Venous System in Neurodegenerative Disorders

  • Chapter
  • First Online:
Cerebral Venous System in Acute and Chronic Brain Injuries

Part of the book series: Springer Series in Translational Stroke Research ((SSTSR))

  • 496 Accesses

Abstract

The role of cerebral venous system in the pathogenesis of neurodegenerative diseases remains largely unknown and underinvestigated. Recent studies have suggested that several neurodegenerative disorders, such as Parkinson’s disease, multiple sclerosis, appear to be associated with venous dysfunction. Unlike the cerebral arterial system, the spatial organization of cerebral venous system is more complicated and often asymmetric, with greater structural heterogeneity than cerebral arterial anatomy. Consequently, this system has been far less studied and understood. Currently, there is an intense debate on whether cerebral venous system dysfunction can influence neurological diseases. In this chapter, we review the role of cerebral venous system in neurodegenerative diseases and aim to give some new concepts on the pathogenesis of neurodegenerative diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Burns A, Iliffe S. Alzheimer’s disease. BMJ. 2009;338:b158.

    Article  Google Scholar 

  2. Lugli M, Morelli M, Guerzoni S, Maleti O. The hypothesis of patho-physiological correlation between chronic cerebrospinal venous insufficiency and multiple sclerosis: rationale of treatment. Phlebology. 2012;27(Suppl 1):178–86.

    Article  Google Scholar 

  3. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28(3):652–9.

    Article  CAS  Google Scholar 

  4. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology. 2008;71(11):804–11.

    Article  Google Scholar 

  5. Bohnen NI, Albin RL. White matter lesions in Parkinson disease. Nat Rev Neurol. 2011;7(4):229–36.

    Article  Google Scholar 

  6. Lai AY, Dorr A, Thomason LA, Koletar MM, Sled JG, Stefanovic B, McLaurin J. Venular degeneration leads to vascular dysfunction in a transgenic model of Alzheimer’s disease. Brain. 2015;138(Pt 4):1046–58.

    Article  Google Scholar 

  7. Weller RO, Boche D, Nicoll JA. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol. 2009;118(1):87–102.

    Article  CAS  Google Scholar 

  8. Michaud JP, Bellavance MA, Prefontaine P, Rivest S. Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep. 2013;5(3):646–53.

    Article  CAS  Google Scholar 

  9. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–17.

    Article  CAS  Google Scholar 

  10. Ge Y, Law M, Herbert J, Grossman RI. Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. AJNR Am J Neuroradiol. 2005;26(9):2316–9.

    PubMed  Google Scholar 

  11. Kalogeris TJ, Kevil CG, Laroux FS, Coe LL, Phifer TJ, Alexander JS. Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells. Am J Phys. 1999;276(1 Pt 1):L9–L19.

    CAS  Google Scholar 

  12. Amberger A, Maczek C, Jurgens G, Michaelis D, Schett G, Trieb K, Eberl T, Jindal S, Xu Q, Wick G. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones. 1997;2(2):94–103.

    Article  CAS  Google Scholar 

  13. Zakkar M, Luong le A, Chaudhury H, Ruud O, Punjabi PP, Anderson JR, Mullholand JW, Clements AT, Krams R, Foin N, Athanasiou T, Leen EL, Mason JC, Haskard DO, Evans PC. Dexamethasone arterializes venous endothelial cells by inducing mitogen-activated protein kinase phosphatase-1: a novel antiinflammatory treatment for vein grafts? Circulation. 2011;123(5):524–32.

    Article  CAS  Google Scholar 

  14. Sharp CD, Houghton J, Elrod JW, Warren A, Jackson TH 4th, Jawahar A, Nanda A, Minagar A, Alexander JS. N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. Am J Physiol Heart Circ Physiol. 2005;288(4):H1893–9.

    Article  CAS  Google Scholar 

  15. Wachtel M, Frei K, Ehler E, Fontana A, Winterhalter K, Gloor SM. Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci. 1999;112(Pt 23):4347–56.

    CAS  PubMed  Google Scholar 

  16. Cao L, Wang H, Wang F. Amyloid-beta-induced matrix metalloproteinase-9 secretion is associated with retinal pigment epithelial barrier disruption. Int J Mol Med. 2013;31(5):1105–12.

    Article  CAS  Google Scholar 

  17. Carden D, Xiao F, Moak C, Willis BH, Robinson-Jackson S, Alexander S. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Phys. 1998;275(2 Pt 2):H385–92.

    CAS  Google Scholar 

  18. Minagar A, Alexander JS, Schwendimann RN, Kelley RE, Gonzalez-Toledo E, Jimenez JJ, Mauro L, Jy W, Smith SJ. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial. Arch Neurol. 2008;65(2):199–204.

    Article  Google Scholar 

  19. Alexander JS, Harris MK, Wells SR, Mills G, Chalamidas K, Ganta VC, McGee J, Jennings MH, Gonzalez-Toledo E, Minagar A. Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b. Mult Scler. 2010;16(7):801–9.

    Article  CAS  Google Scholar 

  20. Minagar A, Ostanin D, Long AC, Jennings M, Kelley RE, Sasaki M, Alexander JS. Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells. Mult Scler. 2003;9(3):235–8.

    Article  CAS  Google Scholar 

  21. Kevil CG, Oshima T, Alexander JS. The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability. Endothelium. 2001;8(2):107–16.

    Article  CAS  Google Scholar 

  22. Adams CW, Abdulla YH, Torres EM, Poston RN. Periventricular lesions in multiple sclerosis: their perivenous origin and relationship to granular ependymitis. Neuropathol Appl Neurobiol. 1987;13(2):141–52.

    Article  CAS  Google Scholar 

  23. Radak D, Kolar J, Tanaskovic S, Sagic D, Antonic Z, Mitrasinovic A, Babic S, Nenezic D, Ilijevski N. Morphological and haemodynamic abnormalities in the jugular veins of patients with multiple sclerosis. Phlebology. 2012;27(4):168–72.

    Article  CAS  Google Scholar 

  24. Pollman MJ, Naumovski L, Gibbons GH. Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation. 1999;99(15):2019–26.

    Article  CAS  Google Scholar 

  25. Jacob T, Hingorani A, Ascher E. Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins. J Vasc Surg. 2005;41(3):523–30.

    Article  Google Scholar 

  26. Saito S, Trovato MJ, You R, Lal BK, Fasehun F, Padberg FT Jr, Hobson RW 2nd, Duran WN, Pappas PJ. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg. 2001;34(5):930–8.

    Article  CAS  Google Scholar 

  27. Liu M, Kluger MS, D’Alessio A, Garcia-Cardena G, Pober JS. Regulation of arterial-venous differences in tumor necrosis factor responsiveness of endothelial cells by anatomic context. Am J Pathol. 2008;172(4):1088–99.

    Article  CAS  Google Scholar 

  28. Lin Z, Kumar A, SenBanerjee S, Staniszewski K, Parmar K, Vaughan DE, Gimbrone MA Jr, Balasubramanian V, Garcia-Cardena G, Jain MK. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res. 2005;96(5):e48–57.

    Article  CAS  Google Scholar 

  29. Hamik A, Lin Z, Kumar A, Balcells M, Sinha S, Katz J, Feinberg MW, Gerzsten RE, Edelman ER, Jain MK. Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem. 2007;282(18):13769–79.

    Article  CAS  Google Scholar 

  30. Sen-Banerjee S, Mir S, Lin Z, Hamik A, Atkins GB, Das H, Banerjee P, Kumar A, Jain MK. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation. 2005;112(5):720–6.

    Article  CAS  Google Scholar 

  31. Ohnesorge N, Viemann D, Schmidt N, Czymai T, Spiering D, Schmolke M, Ludwig S, Roth J, Goebeler M, Schmidt M. Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4). J Biol Chem. 2010;285(34):26199–210.

    Article  CAS  Google Scholar 

  32. Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, Mason JC. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Haemost. 2007;5(12):2537–46.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Tangdu Hospital, PLA Air Force Medical University, Xian, China

    Yan Qu, Lei Zhao & Hao Guo

Authors
  1. Yan Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hao Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, The Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, China

    Min Lou

  2. Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China

    Jianmin Zhang

  3. Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    Yilong Wang

  4. Department of Neurosurgery Tangdu Hospital, PLA Air Force Medical University, Xian, USA

    Yan Qu

  5. Department of Neurology, Medical University of South Carolina, Charleston, SC, USA

    Wuwei Feng

  6. Xuanwu Hospital Neurosurgery, Capital Medical University, Beijing, China

    Xunming Ji

  7. Department of Anesthesiology and Physiology, Loma Linda University, Loma Linda, CA, USA

    John H. Zhang

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Qu, Y., Zhao, L., Guo, H. (2019). Role of Cerebral Venous System in Neurodegenerative Disorders. In: Lou, M., et al. Cerebral Venous System in Acute and Chronic Brain Injuries. Springer Series in Translational Stroke Research. Springer, Cham. https://doi.org/10.1007/978-3-319-96053-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-96053-1_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-96052-4

  • Online ISBN: 978-3-319-96053-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation